Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by doctordeaconon Feb 03, 2017 7:13pm

87 Views

Post# 25798220

RE:RE:PI clients are wong and blizerean and perkins

silkroad you never blew 30k at the rino or lost 150k at the aria poker room or rented a cottage at bellagio for 30k a month ,danced with britney spears and ran your tonque down her sweaty cleavage .
People like wong are nose -bleed stake players and blizerean is buying more .next week.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading